Posizioni attive di Jens Kjeldsen-Kragh
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Prophylix AS
 Prophylix AS Pharmaceuticals: MajorHealth Technology Prophylix AS operates as biotech company that offers orphan drug programs and follow-on therapy. The firm develops a prophylactic medicinal product to prevent newborns from Foetal/Neonatal Alloimmune Thrombocytopenia (FNAIT). The company was founded by Bjørn Ragnar Skogen, Jens Kjeldsen-Kragh, Anne Husebekk, and Mette Kjaer in 2008 and is headquartered in Tromso, Norway. | Direttore Tecnico/Scientifico/R&S | 15/04/2010 | - |
| Fondatore | 01/01/2008 | - |
Storia della carriera di Jens Kjeldsen-Kragh
Precedenti posizioni note di Jens Kjeldsen-Kragh
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| University of Oslo | Corporate Officer/Principal | - | - |
Statistiche
Distribuzione geografica
| Norvegia | 3 |
Posizioni
| Chief Tech/Sci/R&D Officer | 1 |
| Founder | 1 |
| Corporate Officer/Principal | 1 |
Settori
| Health Technology | 2 |
| Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 1 |
|---|---|
Prophylix AS
Prophylix AS Pharmaceuticals: MajorHealth Technology Prophylix AS operates as biotech company that offers orphan drug programs and follow-on therapy. The firm develops a prophylactic medicinal product to prevent newborns from Foetal/Neonatal Alloimmune Thrombocytopenia (FNAIT). The company was founded by Bjørn Ragnar Skogen, Jens Kjeldsen-Kragh, Anne Husebekk, and Mette Kjaer in 2008 and is headquartered in Tromso, Norway. | Health Technology |
- Borsa valori
- Insiders
- Jens Kjeldsen-Kragh
- Esperienza
